...And, I remind you, in this day and age with fund raising is easier than ever and with social media moving good news at light speed, DCVAX-L should be in orbit by now with revenue IF it worked.
If it can only help "a few" L is exactly where it belongs with charity raised funds. Tax payers are not here to make biotech execs wealthy while starving real solutions of cash.
Very well said, and nor are the MHRA there to award an MAA for the sole purpose of a near bankrupt small Biotech Company being able to use it to leverage more borrowing off. And they certainly don’t grant it so that the approval can be bought by the highest bidder in a buyout ‘ The NICE will also show this ‘Vaccine’ the door also. It’s overpriced, and nowhere near ‘effective’ enough, because who pays for the 87% of treatments that result in no meaningful extension of OS ?